Subscribe (Free) to
Daily or Weekly Newsletters
Post a Job

Featured Jobs

Remittance Specialist

Daybright Financial
(Rochester NY / Fort Walton Beach FL / Hybrid)

Daybright Financial logo

Distribution Reviewer

Nova 401(k) Associates
(Remote)

Nova 401(k) Associates logo

Participant Support Representative

Daybright Financial
(Rochester NY / Hybrid)

Daybright Financial logo

Participant Services Representative I - Health & Welfare

BPAS
(Spokane WA / Hybrid)

BPAS logo

Relationship Manager/ Actuary

Daybright Financial
(Remote)

Daybright Financial logo

Senior Distributions Analyst

PCS Retirement
(Remote)

PCS Retirement logo

Benefits Analyst

Hydro
(Des Plaines IL / Hybrid)

Hydro logo

Relationship Manager - DC

Daybright Financial
(Remote)

Daybright Financial logo

Participant Services Representative

BPAS
(Utica NY / Hybrid)

BPAS logo

View More Employee Benefits Jobs

Free Newsletters

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Mobile app icon
LinkedIn icon     Twitter icon     Facebook icon

Press Releases by Date   |   Press Releases by Company Name


View More Press Releases by Magellan Health

Press Release

Magellan Rx Management Achieves Perfect CMS Audit for Medicare Part D

Issued by Magellan Health

Mar. 14, 2022

FRISCO, Texas  – Magellan Health, Inc. today announced that Magellan Rx Management (MRx), the full-service pharmacy benefit management division of the company, received a perfect audit score from the Centers for Medicare & Medicaid Services (CMS) for its Granite Alliance Insurance Company Employer Group Waiver Plan (EGWP), a type of Medicare Prescription Drug (Part D) plan. The plan provides prescription drug benefits for eligible individuals 65 years and older and eligible individuals with disabilities.

The program audit was conducted in September 2021 and tested three main areas of the program: Compliance Program Effectiveness (CPE); Formulary and Benefit Administration (FA); Coverage and Coverage Determinations, Appeals, and Grievances (CDAG). The results of the audit showed zero invalid data submissions, zero findings, zero observations, and zero “Corrective Action Plans Required” (CARs) or “Immediate Corrective Action Plans Required” (ICARs).

“It is truly remarkable to see zero conditions, zero observations, and a glowing review from CMS across all areas that were audited - CDAG, Formulary Administration, and Compliance Program Effectiveness,” said Mostafa Kamal, chief executive officer at Magellan Rx Management. “I’m incredibly proud of our team and their daily commitment to support the Medicare beneficiaries that our clients entrust us with, and this CMS audit result is further validation of Magellan Rx Management’s relentless pursuit of excellence.”

About Magellan Rx Management: Magellan Rx Management, a division of Magellan Health, Inc., is a next-generation pharmacy organization that is delivering meaningful solutions to the people we serve. As pioneers in specialty drug management, industry leaders in Medicaid pharmacy programs and disruptors in pharmacy benefit management, we partner with our customers and members to deliver a best-in-class healthcare experience.

About Magellan Health: Magellan Health, Inc. a is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of addressing the whole health needs of members through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.

View More Press Releases by Magellan Health


Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink.